& Johnson Johnson's Net Worth
$4.15 Billion
Who is & Johnson Johnson?
& Johnson Johnson has an estimated net worth of $4.15 Billion. This is based on reported shares across multiple companies, which include CVRx, Inc., Fusion Pharmaceuticals Inc., Provention Bio, Inc., Inspire Medical Systems, Inc., ACHILLION PHARMACEUTICALS INC, Minerva Neurosciences, Inc., Protagonist Therapeutics, Inc, AQUINOX PHARMACEUTICALS, INC, NEVRO CORP, Aldeyra Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., TENGION INC, BARRIER THERAPEUTICS INC, IMMUNICON CORP, CRITICAL THERAPEUTICS INC, UNIVERSAL BIOSENSORS INC, EXEGENICS INC, ANIMAS CORP, CLOSURE MEDICAL CORP, Kenvue Inc., MeiraGTx Holdings plc, and Contineum Therapeutics, Inc..
SEC CIK
& Johnson Johnson's CIK is 0000200406
Past Insider Trading and Trends
2023 was & Johnson Johnson's most active year for disposing of shares, totalling 1 transactions. & Johnson Johnson's most active month to dispose stocks was the month of July. In 2023 & Johnson Johnson cashed out on 1,533,830,450 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CVRx, Inc. (CVRX) Snapshot price: $8.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.39% | 607.86K |
$12.99 | $2,670.50 | 4.1M |
Feb 16 - Feb 29
| |||
Form 4
|
∞
| 3.5M |
—
|
—
| 3.5M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fusion Pharmaceuticals Inc. (FUSN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.67M |
$17.00 |
—
| 3.67M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Provention Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.4M |
—
|
—
| 2.4M |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inspire Medical Systems, Inc. (INSP) Snapshot price: $210.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 235.25K |
—
|
—
| 235.25K |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -18.37M |
$2.75 | -$50,510,201.50 |
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||